Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
Expert Opinion on Investigational Drugs
|
October 1, 2013
Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases
Jerry R Colca, Steven P Tanis, William G McDonald, et al.
Expert Opinion on Investigational Drugs
|
September 27, 2023
Insulin sensitizers in 2023: lessons learned and new avenues for investigation
Jerry R Colca, Steven P Tanis, Rolf F Kletzien, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 27, 2014
An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss
Tomohiro Fukunaga, Wei Zou, Nidhi Rohatgi, et al.
Hepatology Communications
|
February 7, 2018
Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
Jerry R Colca, William G McDonald, Kyle S McCommis, et al.
Molecular Neurobiology
|
July 27, 2022
Re-routing Metabolism by the Mitochondrial Pyruvate Carrier Inhibitor MSDC-0160 Attenuates Neurodegeneration in a Rat Model of Parkinson's Disease
David Mallet, Raphael Goutaudier, Emmanuel L Barbier, et al.
The Journal of Biological Chemistry
|
May 22, 2021
Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide
Dakota R Kamm, Kelly D Pyles, Martin C Sharpe, et al.
Plos One
|
May 8, 2013
Novel insulin sensitizer modulates nutrient sensing pathways and maintains β-cell phenotype in human islets
Nidhi Rohatgi, Haytham Aly, Connie A Marshall, et al.
Current Alzheimer Research
|
June 17, 2014
An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease
Raj C Shah, Dawn C Matthews, Randolph D Andrews, et al.
Cell Metabolism
|
September 8, 2015
Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling
Kyle S McCommis, Zhouji Chen, Xiaorong Fu, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 23, 2003
Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe
Jerry R Colca, William G McDonald, Daniel J Waldon, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
Expert Opinion on Investigational Drugs
|
October 1, 2013
Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases
Jerry R Colca, Steven P Tanis, William G McDonald, et al.
Expert Opinion on Investigational Drugs
|
September 27, 2023
Insulin sensitizers in 2023: lessons learned and new avenues for investigation
Jerry R Colca, Steven P Tanis, Rolf F Kletzien, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 27, 2014
An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss
Tomohiro Fukunaga, Wei Zou, Nidhi Rohatgi, et al.
Hepatology Communications
|
February 7, 2018
Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
Jerry R Colca, William G McDonald, Kyle S McCommis, et al.
Molecular Neurobiology
|
July 27, 2022
Re-routing Metabolism by the Mitochondrial Pyruvate Carrier Inhibitor MSDC-0160 Attenuates Neurodegeneration in a Rat Model of Parkinson's Disease
David Mallet, Raphael Goutaudier, Emmanuel L Barbier, et al.
The Journal of Biological Chemistry
|
May 22, 2021
Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide
Dakota R Kamm, Kelly D Pyles, Martin C Sharpe, et al.
Plos One
|
May 8, 2013
Novel insulin sensitizer modulates nutrient sensing pathways and maintains β-cell phenotype in human islets
Nidhi Rohatgi, Haytham Aly, Connie A Marshall, et al.
Current Alzheimer Research
|
June 17, 2014
An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease
Raj C Shah, Dawn C Matthews, Randolph D Andrews, et al.
Cell Metabolism
|
September 8, 2015
Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling
Kyle S McCommis, Zhouji Chen, Xiaorong Fu, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
October 23, 2003
Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe
Jerry R Colca, William G McDonald, Daniel J Waldon, et al.
Page
of 5